...
首页> 外文期刊>Pathology Research and Practice >The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4
【24h】

The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4

机译:DNA损伤修复蛋白Ku70通过与FOXO4相互作用调节肿瘤细胞和肝癌的发生

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The capability for DNA double-strand breaks (DSBs) repair is crucial for chromatin dramatic changes and DNA damage in normal and tumor cells. We have investigated the clinicopathological significance of DNA repair gene Ku70 expression in hepatocellular carcinoma. We demonstrated that Ku70 expression was significantly increased in HCC, and the high expression levels were significantly correlated with gender, maximal tumor size, HBsAg status, tumor nodule number, distant metastasis and Ki-67 expression by clinicopathological analysis. The Kaplan Meier survival curves revealed that increasing Ku70 expression was associated with poor prognosis in HCC patients. Ku70 expression was an independent prognostic marker of overall HCC patient survival in a multivariate analysis. In addition, through serum starvation and refeeding, we found that Ku70 was lowly expressed in serum-starved Huh7 and HepG2 HCC cells, and was progressively increased after serum-additioning. Furthermore, knockdown of Ku70 inhibited cell proliferation accompanying an increase in p27kiP1 levels through interacting with FOX04. These findings provide a rational framework for the progression of HCC and could be a potential molecular therapy by targeting the Ku70 FOX04 interaction. (C) 2015 Elsevier GmbH. All rights reserved.
机译:DNA双链断裂(DSB)修复的能力对于正常细胞和肿瘤细胞的染色质急剧变化和DNA损伤至关重要。我们研究了肝细胞癌中DNA修复基因Ku70表达的临床病理意义。我们通过临床病理分析证明,Ku70表达在肝癌中显着增加,并且高表达水平与性别,最大肿瘤大小,HBsAg状态,肿瘤结节数,远处转移和Ki-67表达显着相关。 Kaplan Meier生存曲线显示,Ku70表达增加与HCC患者预后不良有关。在多变量分析中,Ku70表达是整个HCC患者生存的独立预后指标。此外,通过血清饥饿和补料,我们发现Ku70在血清饥饿的Huh7和HepG2 HCC细胞中低表达,并在添加血清后逐渐升高。此外,通过与FOX04相互作用,敲除Ku70可抑制细胞增殖,伴随p27kiP1水平升高。这些发现为肝癌的发展提供了合理的框架,并且可能通过靶向Ku70 FOX04相互作用而成为潜在的分子疗法。 (C)2015 Elsevier GmbH。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号